Key facts
- It has raised $28.0M; the latest was Early Stage VC ($28.0M) in Feb 2026.
- Notable investors include Flare Capital Partners, Rubicon Founders.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Atlas Oncology Partners
- ·The full record, as it builds
Funding rounds
No funding rounds for Atlas Oncology Partners are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Atlas Oncology Partners
Provider of healthcare services intended to deliver uplifting and responsive cancer care during and beyond treatment. The company offers a system that delivers quality care experiences while easing the economic strain of cancer treatment, combines patient navigation, psychosocial and supportive care, proactive care coordination, and expanded in-person and virtual clinical access, enabling professionals to provide standard oncology care to patients.
- Sector
- Healthcare
- HQ
- Knoxville, TN, United States
- Founded
- 2025
- Employees
- 9
- Website
- atlasoncpartners.com/
- Ownership
- Privately Held (backing)
Atlas Oncology Partners doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Atlas Oncology Partners shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Atlas Oncology Partners in its N-PORT filings yet. We sweep new filings monthly.